Mycotopia Therapies Inc. announced today it has initiated plans for a psilocybin-based pharmaceutical program by entering into an agreement to form a 50/50 joint venture with Agile Pharmaceutical Solutions to develop novel oral dosage forms of psilocybin in the form of a psychedelic sublingual tablet.
Category Press Release
Country United States of America
Companies Featured
Mycotopia TherapiesMycotopia are researching and developing psychedelic therapies for mental disorders including; anxiety, depression, bipolar disorders, PTSD, ADHD, autism and addictions.